Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Depreciation & Amortization - Total (2019 - 2024)

Nephros (NEPH) has 11 years of Depreciation & Amortization - Total data on record, last reported at $1000.0 in Q1 2024.

  • For Q1 2024, Depreciation & Amortization - Total changed 0.0% year-over-year to $1000.0; the TTM value through Dec 2024 reached $1000.0, down 66.67%, while the annual FY2023 figure was $3000.0, 86.36% down from the prior year.
  • Depreciation & Amortization - Total reached $1000.0 in Q1 2024 per NEPH's latest filing, roughly flat from $1000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $22000.0 in Q2 2022 and bottomed at -$5000.0 in Q4 2021.
  • Average Depreciation & Amortization - Total over 4 years is $3900.0, with a median of $2000.0 recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization - Total: soared 175.0% in 2022, then crashed 95.45% in 2023.
  • A 4-year view of Depreciation & Amortization - Total shows it stood at -$5000.0 in 2021, then surged by 160.0% to $3000.0 in 2022, then tumbled by 66.67% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization - Total were $1000.0 in Q1 2024, $1000.0 in Q3 2023, and $1000.0 in Q2 2023.